Veracyte VCYT
Valuation
Multiples measured against the stock's own five-year history
Above its usual level · 66th percentile, 5-year average -16.4x
#1263 of 2993 stocks by PE (1 = cheapest)
Near the bottom of its 5-year range · 7th percentile, 5-year average 2.0x
#2162 of 5330 stocks by PB (1 = cheapest)
Near the bottom of its 5-year range · 0th percentile, 5-year average 6.3x
#3371 of 5155 stocks by PS (1 = cheapest)
P/E over five years
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Morningstar fair value estimate
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 1.37 | – | 1.98 | 7% (cheaper than usual) | #2162 of 5330 (1 = cheapest) |
| PE | 15.80 | 23.65 | -16.41 | 66% (pricier than usual) | #1263 of 2993 (1 = cheapest) |
| PS | 3.37 | 3.17 | 6.32 | 0% (cheaper than usual) | #3371 of 5155 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on VCYT.
Sign in to join the discussion.